Fig. 3From: Redox-responsive tumor targeted dual-drug loaded biocompatible metal–organic frameworks nanoparticles for enhancing anticancer effectsThe in vitro release of 5-FU from 5-FU-DCA-UiO-DTDP-FA (a), and viabilities of MDA-MB-231 cancer cells (b) cultured with 5-FU, 5-FU + DCA, and 5-FU-DCA-UiO-DTDP-FABack to article page